Navigation Links
DrugRisk Update: Evidence Submitted in Actos Lawsuit Suggests Drug Maker Knew of Cancer Risks
Date:3/19/2013

New York, NY (PRWEB) March 19, 2013

The prescription drug resource center DrugRisk.com is alerting patients who have taken the drug Actos of updated legal news on the site. The resource site learned this week of new evidence showing the manufacturer may have known of the risks of bladder cancer in 2003, but did nothing to warn patients.

“The goal of DrugRisk is to improve consumer safety by publishing the latest drug warnings, recalls, studies and litigation news. Informed patients can discuss options with their doctor and decide if they need legal advice,” explains DrugRisk representative Ryan Mayer.

The resource center contains Actos warnings from both the FDA* and European Medicines Agency** who indicated that long-term use of the drug may be associated with an increased risk of bladder cancer. The drug has also been banned in France and Germany.***

In legal news, Takeda, the maker of Actos faces as many as 3,000 claims over Actos bladder cancer.**** More than 1,200 patients have filed an Actos lawsuit against the drug maker in a special multi-district federal court in Louisiana.***** Other cases have been filed in California.****

The first Actos trial began this month in California. Now, DrugRisk has learned that lawyers representing a man dying of cancer in that trial filed a study on January 25th which shows Takeda asked doctors in 2003 if they would still prescribe a diabetes drug that had bladder cancer risks. However, they didn’t disclose their concerns to patients.****

Lawyers are still helping those affected file claims. Anyone diagnosed with bladder cancer after taking Actos is urged to contact the DrugRisk Resource Center or speak with a lawyer about their legal rights as soon as possible.

Due to the specialized nature of defective drug injury cases, DrugRisk only recommends lawyers and law firms who have already handled Actos lawsuits.

For more information on the research, side effects, litigation news and a potential Actos recall or to speak with a lawyer, visit http://www.DrugRisk.com.

*fda.gov/ForConsumers/ConsumerUpdates/ucm263431.htm#Actos
**http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2011/07/news_detail_001311.jsp&mid=WC0b01ac058004d5c1
***cbsnews.com/8301-504763_162-20070492-10391704.html
****businessweek.com/news/2013-02-15/takeda-worried-about-actos-s-cancer-link-filing-shows
***** In Re: Actos Products Liability Litigation, MDL 2299, U.S. District Court, Western District of Louisiana (Lafayette).

Read the full story at http://www.prweb.com/releases/actos-recall/actos-lawsuits/prweb10491110.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisk Update: Bayer Discloses $500 Million Remaining for Yaz Lawsuits
2. DrugRisk Pradaxa Update: Litigation Grows As New Study Adds to Risks
3. DrugRisk Pradaxa Lawsuit Update: Court Denys Boehringer’s Protective Order Request
4. DrugRisk Update: Court Allows Charges of Prior Fraud Into Pradaxa Lawsuit
5. DrugRisk Update: NuvaRing Lawsuit Trials to Begin This Year
6. DrugRisk Announces New Pradaxa Health Warning From Australia
7. DrugRisk Adds Latest Health Warnings and Lawsuit Updates for Yaz
8. DrugRisk Announces Updated Information on Mirena Lawsuits
9. DrugRisk Announces Alternative to Mirena IUD May Be Available Soon
10. DrugRisk Center Announces Court Postponement of NuvaRing Lawsuits
11. Update: Number of Stryker Rejuvenate Hip Recall Lawsuits Growing in New Jersey Multicounty Litigation, Announces Wright & Schulte LLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/19/2017)... ... , ... ProBrand Glitch is a set of 30 glitch distortion logo reveals made exclusively for ... logo with a glitch reveal in just a few clicks of a mouse. Customizable glitch ... each preset. Use these presets to add a uniquely animated logo to any photos or ...
(Date:2/18/2017)... VA (PRWEB) , ... February ... ... of Change for Devicemakers , Sponsored by Axendia, **FDAnews Free Webinar**, March ... , Are manufacturers looking to reduce their regulatory burden? Pay dividends in ...
(Date:2/18/2017)... , ... February 17, 2017 , ... ... drvallecillos.com , Beverly Hills plastic surgeon Dr. Glenn Vallecillos ... , Dr. Vallecillos says, "Traditionally, plastic surgery has been centered around that idea ...
(Date:2/18/2017)... La. (PRWEB) , ... February 18, 2017 , ... ... released today provides the latest information and contact points to easily connect elderly ... home care, assisted living, and elder-care funding. It also conveys material on this ...
(Date:2/17/2017)... Diego, CA (PRWEB) , ... February 17, 2017 ... ... initiative—InvestUp—to focus on foundational and sustainable systems change designed to further positively impact ... , “The Board of Trustees has long considered it our duty to seriously ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... , Feb. 17, 2017  Perrigo Company plc (NYSE, TASE: PRGO) ... Food and Drug Administration for hydrocodone bitartrate and homatropine methylbromide ... Hydrocodone bitartrate and homatropine methylbromide oral solution (syrup), ... symptomatic relief of cough in adults and children 6 years ... ending January 2017 were approximately $16 million.   ...
(Date:2/17/2017)... , Feb. 17, 2017  In partnership with ... for Good Health , The Jack Brewer Foundation ... with millions of dollars, worth of medicine to ... . IHI is a non-profit dedicated to treating chronic ... extremely active in Haiti and ...
(Date:2/17/2017)... NEW YORK , February 17, 2017 ... Composite and the S&P 500 edged lower at the ... its bullish streak above the 20,000 benchmark. Moreover, five ... bearish territories. Taking into consideration yesterday,s market sentiment, Stock-Callers.com ... morning: Smith & Nephew PLC (NYSE: SNN ...
Breaking Medicine Technology: